§ BIOTECHNOLOGY
USD · BiotechnologyVRDN
VIRIDIAN THERAPEUTICS INC
USDSector · BiotechnologyBeta · 0.94
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
147 increased/new, 56 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 4.11 | EPS (TTM) | -3.96 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Fidelity Management | 15.4M | 0.0% | +7% |
| BlackRock, Inc. | 7.8M | 0.0% | +22% |
| Bellevue Group AG | 6.7M | 3.1% | +54% |
| State Street | 4.7M | 0.0% | +35% |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.2M | n/a | n/a |
| Fairmount Funds Management LLC | 3.9M | 5.5% | ±0% |
◇ AC INTELLIGENCE
Top institutional owners for VRDN as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER93.8% · 0 holders
OTHER3.4% · 154 holders
QUALITY / COMPOUNDER1.2% · 16 holders
DEALER / BANK0.6% · 24 holders
PASSIVE / INDEX0.6% · 9 holders
TACTICAL / MACRO0.2% · 3 holders
ACTIVIST0.1% · 1 holder
SYSTEMATIC / QUANT0.0% · 6 holders
INCOME / DEFENSIVE0.0% · 13 holders
GROWTH / MOMENTUM0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for VRDN in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention VRDN yet.